ValueTheMarkets Podcast 033 - with Ray Barlow, CEO of E-Therapeutics (ETX)

By Patricia Miller


Today’s guest on the ValueTheMarkets podcast is Dr Ray Barlow, CEO of E-Therapeutics (LSE:ETX). The company is employing a computer-based approach to the discovery of new drugs. It’s Network-Driven Discovery (NDD) platform employs techniques such as machine learning, artificial intelligence, and data analysis to find better drug solutions in a more efficient manner.

In the interview, Ray discusses the NDD platform, the company’s business model, the changes he’s made since joining the board in 2017, and talks about his background in the industry.


Author: Patricia Miller

This article does not provide any financial advice and is not a recommendation to deal in any securities or product. Investments may fall in value and an investor may lose some or all of their investment. Past performance is not an indicator of future performance.

Sign up for Investing Intel Newsletter